Market News & Trends
Lupin Acquires Nanomi, Heading Toward Complex Injectables Space
Pharmaceutical major Lupin Limited recently announced the acquisition of Nanomi B.V. in the Netherlands. With this acquisition, Lupin has made its foray into the technology…
WellSpring Pharma Services Expands Business Development Capabilities
WellSpring Pharma Services recently announced the addition of Mr. Lonnie Barish, MBA, as Executive Director, Business Development, and Mr. David Watt as Technical Director, Pharma…
EMD MilliporeLaunches New System for More Powerful Benchtop Cell Analysis
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently launched the guava easyCyte 12 flow cytometry system, which provides a simple…
Domain Therapeutics Enters Collaboration With XOMA
Domain Therapeutics recently announced it has entered into a multi-step collaboration with XOMA Corporation. XOMA focuses its research on allosteric modulation, which offers opportunities for…
Merck & Ablynx Sign Global Agreement
Ablynx recently announced it has entered into a second research collaboration and licensing agreement with a subsidiary of Merck & Co., known outside the US…
A Silk Coat for Diamonds Makes Sleek New Imaging and Drug Delivery Tool
Silk and diamonds aren't just for ties and jewelry anymore. They're ingredients for a new kind of tiny glowing particle that could provide doctors and…
Novozymes Biopharma Announces New Data Highlighting Potential for Monthly Drug Dosing
Novozymes Biopharma recently announced new data on extending the serum half-life of albumin in vivo. This compelling data set, recently presented at PepTalk 2014, demonstrates…
Strong Pipeline of Monoclonal Antibodies Biosimilars in the US & Europe Lends Impetus to Global Market
The imminent entry of several companies, including big pharma, small biotech, and generic participants, into the global biosimilars space will propel the market toward exponential…
Gerresheimer Develops Interface for Integrating Glass Syringes in Autoinjectors
The development of autoinjectors generally involves the integration of a prefilled glass syringe into a plastic drug delivery device - a major challenge due to…
Horizon Discovery Signs Large-Scale License Agreement
Horizon Discovery recently announced it has entered into a large-scale licensing agreement with a Japanese medical university. The agreement covers a limited use label license…
Promising New Therapies to Boost Global Hepatitis C Market by 2019
Due to a large untreated patient pool and the recent approval of new treatments, the hepatitis C market will more than treble from $5.7 billion…
Gateway Analytical Acquires RapID System to Meet Growing Market Demand
Gateway Analytical recently announced they have acquired the RapID SPE-ls raman.ID + metal.ID system, the latest technology in automated particle identification. This acquisition enhances existing…
Alexza Pharmaceuticals Announces $1-Million Milestone Payment
Alexza Pharmaceuticals, Inc. recently announced that ADASUVE inhalation powder, predispensed (Staccato loxapine) is now available in Spain through Grupo Ferrer Internacional, S.A. (Ferrer). Ferrer is…
Bladder Cancer Market to Witness Moderate Growth by 2017
The bladder cancer therapeutics market in the six major countries (6MM) - the US, France, Germany, Italy, Spain, and UK - is forecast to climb…
Biocon Collaborates With Advaxis
Biocon Ltd. and Advaxis, Inc. recently announced they have entered into an exclusive licensing agreement for co-development and commercialization of ADXS-HPV, a novel cancer immunotherapy…
Alitair Announces Issuance of Third Patent for its Drug Delivery Platform
Alitair Pharmaceuticals, Inc. recently announced the issuance of US Patent No. 8,617,602 from theUSPTO for its ion exchange resin drug delivery technology, REA. "Our…
Automated Anatomic Pathology Labs Transform Global Tissue Diagnostics Market
Growth in diagnostic test volume conducted across hospitals worldwide is lending momentum to the global tissue diagnostics market. In addition, the shortage of pathologists to…
Bristol-Myers Seeks Innovative Drugs
Bristol-Myers Squibb Co. will continue to seek out innovative drugs to buy, particularly for cancer, shrugging off two previous deals totaling $7.8 billion in the…
Valeant, Actavis, Mylan Pursue Pfizer's Generics Unit
Drugmakers Valeant Pharmaceuticals International Inc., Actavis Plc, and Mylan Inc. have all expressed interest in buying Pfizer Inc's branded generics business, but no active discussions…
Moderna Launches Spin-Off for mRNA-Based Cancer Drugs
With a $110-million financing round and big-time deals with AstraZeneca and Alexion Pharmaceuticals in the bag, biotech company Moderna Therapeutics’ next big move is to…
